August 2, 2016

Among the biosimilars researchers focused on was Inflectra, which was developed by Pfizer’s Hospira as a biosimilar to Janssen Biotech’s Remicade. 

August 1, 2016
Aurobindo has chosen the 90-acre East Windsor campus as its U.S. headquarters, and when the manufacturing and distribution center is fully operational, it is expected to generate 400-500 new jobs. 
July 28, 2016

With the final regulatory hurdle behind it, the company said it expects the $40.5 billion transaction to complete next week.

July 26, 2016

Teva Pharmaceutical and Mylan have shown preliminary interest in a Brazilian generic drug-making joint-venture in which Pfizer has a 40% stake, according to Fortune. (Fortune)

July 25, 2016

Boothe had previously served as Perrigo’s EVP and general manager, where he was responsible for U.S. pharmaceuticals, including generics and specialty.

July 25, 2016

For the 12 months ended May 31, the product had U.S. sales of $6.7 billion. 

July 25, 2016

Pennsylvania Wolf’s signing of Senate Bill 514 has earned him praise from both the Biotechnology Innovation Organization (BIO) and Pennsylvania Bio.

July 22, 2016

Apotex  has launched rosuvastatin calcium tablets, the generic equivalent of Crestor by AstraZeneca.

July 22, 2016

Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products. 

July 20, 2016

The finding points to a potential gap in competition that has allowed prices for some generics to climb.

July 20, 2016

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

July 20, 2016

"Working together with NCPA staff, the Innovation Center will help better position independent community pharmacies to be part of and benefit from broader health care changes," suggested Doug Hoey, NCPA CEO.

July 19, 2016
Ajanta’s Axert generics will be available in 6.25- and 12.5-mg dosage strength. 
July 19, 2016

The drug had U.S. sales of about $15.7 million for the 12 months ended May 2016, according to IMS Health. 

July 18, 2016

ANI’s is the first generic of the Nilandron, which is indicated to treat metastatic prostate cancer in combination with surgical castration. 

July 18, 2016

The drug had U.S. sales of about $306.7 million for the 12 months ended May 2016, according to IMS Health. 

July 15, 2016

In addition to leveraging a pipeline of complex generics across its markets while focusing on OTC, Dr. Reddy's chairman K Satish Reddy said the branded generics would be one of the ways the company drives growth in the coming years.

July 13, 2016
Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)
July 12, 2016

The agency has acted on 90% of the generic drug and prior approval supplement applications pending as of Oct. 1, 2012 — which puts it more than a year ahead of its final deadline of Sept. 30, 2017. 

July 12, 2016

The move is aimed at Nichi-Iko becoming one of the top 10 global generics leaders, and the companies said acquiring Sagent will boost Nichi-Iko’s ability to commercialize its biosimilar pipeline and increase its presence in injectables.

July 6, 2016

Mylan’s fenofibrate tablets will be available in 40- and 120-mg dosage strengths. 

July 5, 2016

For the quarter, the company saw revenues of $723.6 million — a 1.6% rise over the same quarter last year that it attributes to overall market growth and the expansion of its franchised store network.

July 1, 2016
NACDS and NCPA urged the Senate committee to adopt the House’s position in its version of the National Defense Authorization Act , which does not include provisions that would increase TRICARE copays, arguing that higher copays can have detrimental effects on patient health and federal spending. 
June 30, 2016

Toohey is the former president and CEO of the Semiconductor Industry Association, where he oversaw that industry’s federal advocacy, international trade and technology programs, as well as a veteran of PhRMA’s advocacy team.